Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome—A Randomized Controlled Trial

Sympathetic nervous system (SNS) activity is increased in polycystic ovary syndrome (PCOS). Moxonidine is a centrally acting sympatholytic drug with known beneficial effects on hypertension, insulin sensitivity, dyslipidemia and inflammation. In this double-blind placebo controlled randomized clinic...

Descripció completa

Dades bibliogràfiques

Autors principals:	Soulmaz Shorakae, Elisabeth A. Lambert, Eveline Jona, Carolina Ika Sari, Barbora de Courten, John B. Dixon, Gavin W. Lambert, Helena J. Teede
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2018-10-01
Col·lecció:	Frontiers in Physiology
Matèries:	polycystic ovary syndrome sympathetic nervous system insulin resistance moxonidine randomized controlled trial
Accés en línia:	https://www.frontiersin.org/article/10.3389/fphys.2018.01486/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!